Received Mar 24, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 9N9PY | — |
Engerix-B stored at 35.0F for 30 days/Engerix-B administered to 1 patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a adolescent female patient who received HBV (Engerix B) (batch number 9N9PY, expiry date 07-MAY-2027) for prophylaxis. On 16-MAR-2026, the patient received Engerix B. On an unknown date, an unknown time after receiving Engerix B, the patient experienced incorrect storage of drug (Verbatim: Engerix-B stored at 35.0F for 30 days/Engerix-B administered to 1 patient). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 18-MAR-2026 No prior excursions were reported.